Pay in 4 interest-free payments of $5.08 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
The current findings represent very positive news for people living with obesity on GLP-1 therapy and suggest the benefits of this family of treatments may extend to a reduction in cancer risk." References: Glucagon-like peptide-1 therapy in people with obesity restores natural killer cell metabolism and effector function - ( Obesity-Associated Alterations of Natural Killer Cells and Immunosurveillance of Cancer - ( Obesity and overweight - ( Source-Medindia
What should we know about people with eating disorders and using GLP 1 agonists
No long-term hard-outcome data
GLP-1 and GIP reduce hunger and affect how the body handles fat and insulin, and the added glucagon component increases the energy the body uses at rest
But as of this writing, the manufacturer is offering Wegovy for $349 per month for 0.25 mg, 0.5 mg, 1 mg, 1.7 mg, or 2.4 mg doses
US$ 28.54
US$ 20.88
US$ 27.94
US$ 20.13
US$ 29.64
US$ 26.34
US$ 28.42
US$ 24.61
US$ 24.41
